Comparative antihypertensive efficacy of olmesartan: comparison with other angiotensin II receptor antagonists
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://www.nature.com/articles/1001394.pdf
Reference49 articles.
1. Kannel WB . Fifty years of Framingham Study contributions to understanding hypertension J Hum Hypertens 2000 14: 83–90
2. Kannel WB . Blood pressure as a cardiovascular risk factor: prevention and treatment JAMA 1996 275: 1571–1576
3. MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Lancet 1990 335: 765–774
4. Stamler J, Stamler R, Neaton JD . Blood pressure, systolic and diastolic, and cardiovascular risks. US population data Arch Intern Med 1993 153: 598–615
5. Collins R et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 1990 335: 827–838
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats;Clinical and Experimental Pharmacology and Physiology;2022-12-04
2. Preparation of olmesartan medoxomil solid dispersion with sustained release performance by mechanochemical technology;Drug Delivery and Translational Research;2021-04-15
3. Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicine;British Journal of Clinical Pharmacology;2011-06-09
4. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in japanese patients with essential hypertension: Additional results from the REZALT study;Clinical Therapeutics;2010-05
5. A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study;Hypertension Research;2009-10-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3